The outbreak of swine flu, having killed over 100 people in Mexico and already spread to the US, Canada and New Zealand, has given a boost to shares in pharmaceutical companies in anticipation of the need for drugs and flu vaccines, and caused travel and agricultural shares to fall.
Get the full story...
The U.S. Health authorities approved Swiss pharmaceuticals producer Roche Holding AG’s anemia drug Mircera, but the company is still awaiting resolution of a patent case before launching the drug in the United States.
Get the full story...
Ghost authorship is the failure to name, as an author, an individual who has made a substantial contribution to a scientific article. A study of 44 industry-initiated trials from Denmark in the 1990s found evidence of ghost authorship for 33 trials, which increased to 40 if a person qualifying for authorship was just acknowledged rather than being named as an author.
Read the full story
